Clinical Trial Update: Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase II clinical trial of sunitinib in bronchioloalveolar carcinoma or never-smokers with lung adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Swedish Medical Center | Conditions: Lung Cancer, Adenocarcinoma | Phase 2 | Status: COMPLETED